Inventor · disambiguated record
Ronald K. Scheule
Also filed as: SCHEULE RONALD · SCHEULE RONALD K
18 granted patents·16 pending applications·967 citations·filing 1995–2024
96Inventor score
Top patents by PatentIndex Score
34 records- 0196US5948767ACationic amphiphile/DNA complexesGENZYME CORP·Filed 1996·Granted Sep 7, 1999·271 cites·13 claims
- 0294US5783565ACationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Jul 21, 1998·123 cites·4 claims
- 0394US5719131ACationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Feb 17, 1998·119 cites·24 claims
- 0492US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 0592US8003617B2Methods of treating diabetes mellitusGENZYME CORP·Filed 2005·Granted Aug 23, 2011·27 cites·50 claims
- 0692US6071890AOrgan-specific targeting of cationic amphiphile/DNA complexes for gene therapyGENZYME CORP·Filed 1995·Granted Jun 6, 2000·128 cites·14 claims
- 0789US5935936ACompositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 10, 1999·85 cites·20 claims
- 0886US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 0983US9532976B2Method of lowering blood glucoseGENZYME CORP·Filed 2014·Granted Jan 3, 2017·5 cites·33 claims
- 1082US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 1181US5939401ACationic amphiphile compositions for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 17, 1999·37 cites·5 claims
- 1280US5840710ACationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Nov 24, 1998·51 cites·36 claims
- 1375US5910487ACationic amphiphiles and plasmids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Jun 8, 1999·28 cites·7 claims
- 1474US6383814B1Cationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1999·Granted May 7, 2002·32 cites·16 claims
- 1572US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 1669US5747471ACationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted May 5, 1998·37 cites·20 claims
- 1768US11801311B2Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotidesGENZYME CORP·Filed 2020·Granted Oct 31, 2023·0 cites·18 claims
- 1866US10682423B2Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotidesGENZYME CORP·Filed 2018·Granted Jun 16, 2020·0 cites·20 claims
- 1964US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 2057US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
- 2155US6331524B1Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapyGENZYME CORP·Filed 1997·Granted Dec 18, 2001·11 cites·4 claims
- 2253US2010216709A1Systemic insulin-like growth factor-1 therapy reduces diabetic peripheral neuropathy and improves renal function in diabetic nephropathyGENZYME CORP·Filed 2009·Application pending·0 cites
- 2353US2016207933A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2015·Application pending·0 cites
- 2452US2003143266A1Cationic amphiphile micellar complexesGENZYME CORP·Filed 2002·Application pending·0 cites
- 2552US2017182189A1Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotidesGENZYME CORP·Filed 2015·Application pending·0 cites
- 2649US2012022126A1Method Of Treating Diabetes MellitusCHENG SENG H·Filed 2011·Application pending·0 cites
- 2749US2009105141A1Intraventricular protein delivery for amyotrophic lateral sclerosisGENZYME CORP·Filed 2008·Application pending·0 cites
- 2846US2003220277A1Methylation of plasmid vectorsGENZYME CORP·Filed 2002·Application pending·0 cites
- 2943US2008025952A1Methods for targeted deliver of genetic material to the liverSCHEULE RONALD K·Filed 2007·Application pending·0 cites
- 3040US6465007B1Transgene expression in polarized cellsGENZYME CORP·Filed 1999·Granted Oct 15, 2002·6 cites·16 claims
- 3139US2005176672A1Use of cationic lipids to generate anti-tumor immunitySTRESSGEN BIOTECHNOLOGIES·Filed 2005·Application pending·0 cites
- 3230US2002013282A1Cationic amphipile compositions for interacelluar delivery of therapeutic moleculesFiled 1998·Application pending·0 cites
- 3327US2001048940A1Cationic amphiphile micellar complexesFiled 1999·Application pending·0 cites
- 3427US2002042383A1METHYLATION AND/Or CpG REMOVAL OF PLASMID VECTORSFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →